A f-MRI Study Of Affective Changes Associated With Four Weeks Consumption Of A Fermented Dairy Product In Healthy Women
A f-MRI STUDY OF AFFECTIVE CHANGES ASSOCIATED WITH FOUR WEEKS CONSUMPTION OF A FERMENTED DAIRY PRODUCT IN HEALTHY WOMEN
1 other identifier
interventional
51
1 country
1
Brief Summary
The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on the brain activity within specific neural circuits regulating the subjective experience of emotional valence and digestive well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 19, 2011
CompletedFirst Posted
Study publicly available on registry
July 20, 2011
CompletedNovember 25, 2016
November 1, 2016
1.2 years
July 19, 2011
November 23, 2016
Conditions
Keywords
Study Arms (3)
1 = Tested product
EXPERIMENTAL2 = Control product
ACTIVE COMPARATOR3 = No product
NO INTERVENTIONInterventions
Arm 2 - Intervention 2 (control)
Eligibility Criteria
You may qualify if:
- Healthy women, right-handed, aged from 18 to 60 years
- Subject of normal body weight or with overweight i.e. not obese (body mass index between 18 and 30 kg/m2).
- For fertile women, complying with one of the other medically approved methods of contraception
You may not qualify if:
- Subject with any current psychiatric or eating or suicidal attempt disorder, or history of such disorder.
- Subject with any history of chronic GI disorder or disease.
- Subject with any significant active or prior metabolic disorder or disease.
- Subject with any use of probiotic supplements or antibiotics in the previous month.
- Subject with current use of any medications with potential central nervous system effects (antidepressants, anxiolytics, opiate pain medications...).
- Subject with allergy or hypersensitivity to milk proteins or lactose intolerance or immunodeficiency
- Subjects with claustrophobia or other condition (such as metallic implants) that would preclude MRI scanning
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA - University
Los Angeles, California, 90095-7170, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2011
First Posted
July 20, 2011
Study Start
April 1, 2009
Primary Completion
June 1, 2010
Study Completion
December 1, 2010
Last Updated
November 25, 2016
Record last verified: 2016-11